Track: Arthritis, Osteoporosis, and Degenerative Joint Disease

Arthritis, Osteoporosis, and Degenerative Joint Disease

Degenerative and inflammatory joint disease, alongside osteoporosis, together account for a substantial share of the global burden of musculoskeletal disability. This session builds on themes discussed in regenerative medicine and stem cell therapy, examining current management strategies across these interconnected conditions.

Key Topics and Highlights:

Osteoarthritis Pathophysiology and Non-Surgical Management: Understanding cartilage degradation and joint inflammation informs treatment selection. This subtopic covers weight management, physical therapy, and injection-based approaches.

Rheumatoid Arthritis and Biologic Therapy: Disease-modifying and biologic therapies have transformed inflammatory arthritis management. This subtopic examines their impact on the need for surgical intervention.

Osteoporosis Screening and Fracture Risk Assessment: Bone density assessment plays a critical role in fracture prevention, connecting to geriatric orthopedics and bone metabolic disorders. This subtopic reviews current screening guidelines.

Bone Health Optimization Before Arthroplasty: Poor bone quality affects implant fixation and fracture risk. This subtopic addresses preoperative bone health assessment in surgical candidates.

Multidisciplinary Management of Overlapping Conditions: Rheumatologists, endocrinologists, and orthopedic surgeons increasingly collaborate on complex cases. This subtopic explores integrated care models.

If your research addresses degenerative joint disease or bone metabolic health, we welcome you to submit an abstract and contribute to a session with broad relevance across orthopedic practice.